Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022
Wed, May 11, 2022

Nathan Rich Maintained (TEVA) at Hold with Decreased Target to $9 on, May 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-9-on-may-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Rich of Goldman Sachs, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $10 to $9 on, May 12th, 2022.

Nathan has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, January 27th, 2022


These are the ratings of the 2 analyists that currently disagree with Nathan


  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $7 on, Wednesday, May 4th, 2022
  • Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022

Publication Contributing Sources